Bill Sibold joins Sanofi as member of the Executive Committee

News Hour:

Sanofi announced the appointment of Bill Sibold as Executive Vice President Sanofi Genzyme, effective July 1, 2017.  In this role, Mr. Sibold will be a member of the Executive Committee. He succeeds David Meeker, M.D., who will leave the company at the end of June after a distinguished 23-year career with Genzyme and Sanofi.

Mr. Sibold currently serves as head of Sanofi Genzyme’s Global Multiple Sclerosis, Oncology, and Immunology organization, a position he has held since January 2016 and where he has led preparation for the global launches of Dupilumab and Sarilumab.

He joined Sanofi in late 2011 as head of the MS franchise where he oversaw the successful launches of Aubagio® and Lemtrada®. As head of Sanofi Genzyme, Mr. Sibold will now lead the company’s efforts to maintain its leadership in rare diseases while continuing to grow in multiple sclerosis, oncology, and immunology. 

“With a strong commitment to serving patients, Sanofi Genzyme has evolved from a rare disease company into a preeminent specialty care business, deeply rooted in science. I am confident in Bill Sibold’s experience and leadership to build on this strong foundation as we chart the next chapter for Sanofi Genzyme, which has become a real growth driver for Sanofi” said Olivier Brandicourt, Chief Executive Officer, Sanofi. “I would also like to thank David Meeker for his tireless dedication to our shared vision for Sanofi Genzyme and his personal passion for the patients we serve, both of which helped make our company the success it is today.”

Mr. Sibold is from Canada and has more than twenty-five years of experience in the biopharmaceutical industry since starting his career with Eli Lilly. He held a number of leadership positions within Biogen, including driving their U.S. commercial operations in neurology, oncology and rheumatology and general management of Biogen’s Australian and Asia-Pacific business.

In addition to his time with Biogen, Mr. Sibold also served as the chief commercial officer of Avanir Pharmaceuticals. He holds an MBA from Harvard Business School and a BA in Molecular Biophysics and Biochemistry from Yale University.

Avatar

This article has been posted by a News Hour Correspondent. For queries, please contact through [email protected]
No Comments

Translate this News

Join the Facebook Group

Click here to join the Facebook group of News Hour

Popular Posts

Sacred Games exposes Rajshri Deshpande nude [video]
3500 RMG workers in Bangladesh receive banking services for the first time through Sarathi
Ahoy Bangladesh Ltd. making medical treatment in India easy
Anurag Kashyap shoots Kubra Saith 7 times nude and made her cry for frontal nudity scene [Video]
The miracle of Hyperbaric Oxygen Therapy (HBOT) and its potential in Bangladesh
Urban leaders power the future with Oracle

Advertisement

News of the Month

April 2017
S M T W T F S
« Mar   May »
 1
2345678
9101112131415
16171819202122
23242526272829
30  
Scroll Up
%d bloggers like this: